Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Mind Gym (MIND) by Steve Moore in ShareProphets
- Avoid Made Tech Group (MTEC) by Steve Moore in ShareProphets
- Sell Technology Minerals (TM1) by Tom Winnifrith in ShareProphets
- Add Legal & General Group (LGEN) by Charlie Keough in The Motley Fool
- Avoid Aferian (AFRN) by Steve Moore in ShareProphets
- Sell Petrofac Ltd. (PFC) by Lucian Miers in ShareProphets
- Underperform Sainsbury (J) (SBRY) by Bank of America
- Add HSBC Holdings (HSBA) by Charlie Keough in The Motley Fool
- Hold Rolls-Royce Holdings (RR.) by Mark David Hartley in The Motley Fool
- Buy National Grid (NG.) by UBS
- Neutral London Stock Exchange Group (LSEG) by UBS
- Neutral South32 Limited (DI) (S32) by Citi
- Neutral Associated British Foods (ABF) by UBS
- Buy Tinybuild Inc. (DI) (TBLD) by Berenberg
- Hold Learning Technologies Group (LTG) by Berenberg
- Outperform Watches of Switzerland Group (WOSG) by RBC Capital
- Neutral Rentokil Initial (RTO) by JP Morgan
- Neutral easyJet (EZJ) by Goldman Sachs
- Hold Reckitt Benckiser Group (RKT) by Jefferies
- Buy Watches of Switzerland Group (WOSG) by Jefferies
Shield Therapeutics (STX) Share Price
Health Care Sector
NOTE: This is based on 59 open tips for Shield Therapeutics (STX)
| Latest Bid : 1.40p | Latest Ask : 1.45p |
| High Today : 1.43p | Low Today : 1.40p |
| This Years High : 12.50p | This Years Low : 1.40p |
| Volume : 629,860 | MKT Cap : £11.34M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Shield Therapeutics (STX) Overview
Shield is a de-risked commercial stage, pharmaceutical company focused on addressing iron deficiency in adults with or without anaemia. Our clear purpose is to develop products that help patients become people again, enabling them to enjoy the things that make a difference in their everyday lives.Shield Therapeutics (STX) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Corporate | FinnCap | Premium Only | 2019-08-07 09:10:00 07/08/2019 | – |
| Buy | Peel Hunt | Premium Only | 2019-08-07 09:00:00 07/08/2019 | -95.82% |
| Buy | Peel Hunt | Premium Only | 2019-08-01 11:20:00 01/08/2019 | -96.18% |
| Corporate | FinnCap | Premium Only | 2019-07-26 14:30:00 26/07/2019 | – |
| Buy | Peel Hunt | Premium Only | 2019-07-26 11:30:00 26/07/2019 | 49.95% |
Shield Therapeutics (STX) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 1.40p | Latest Ask : 1.45p |
| High Today : 1.43p | Low Today : 1.40p |
| This Years High : 12.50p | This Years Low : 1.40p |
| Volume : 629,860 | MKT Cap : £11.34M |
Shield Therapeutics Overview
Shield is a de-risked commercial stage, pharmaceutical company focused on addressing iron deficiency in adults with or without anaemia. Our clear purpose is to develop products that help patients become people again, enabling them to enjoy the things that make a difference in their everyday lives.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Shield Therapeutics Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Corporate | FinnCap | Premium Only | 2019-08-07 09:10:00 07/08/2019 | – |
| Buy | Peel Hunt | Premium Only | 2019-08-07 09:00:00 07/08/2019 | -95.82% |
| Buy | Peel Hunt | Premium Only | 2019-08-01 11:20:00 01/08/2019 | -96.18% |
| Corporate | FinnCap | Premium Only | 2019-07-26 14:30:00 26/07/2019 | – |
| Buy | Peel Hunt | Premium Only | 2019-07-26 11:30:00 26/07/2019 | 49.95% |